421 related articles for article (PubMed ID: 7448414)
1. Clot retraction facilitates clot lysis.
Carroll RC; Gerrard JM; Gilliam JM
Blood; 1981 Jan; 57(1):44-8. PubMed ID: 7448414
[TBL] [Abstract][Full Text] [Related]
2. A phenomenologic description of clot lysis in dilute human plasma correlating structure and function of platelets.
Gilliam JM; Berkus V; Taylor FB
Am J Pathol; 1979 Jul; 96(1):35-50. PubMed ID: 464023
[TBL] [Abstract][Full Text] [Related]
3. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
Taylor FB; Müller-Eberhard HJ
J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.
Kunitada S; FitzGerald GA; Fitzgerald DJ
Blood; 1992 Mar; 79(6):1420-7. PubMed ID: 1547340
[TBL] [Abstract][Full Text] [Related]
5. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
[TBL] [Abstract][Full Text] [Related]
6. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
[TBL] [Abstract][Full Text] [Related]
7. Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets.
Lockhart MS; Comp PC; Taylor FB
J Lab Clin Med; 1979 Aug; 94(2):285-94. PubMed ID: 458246
[TBL] [Abstract][Full Text] [Related]
8. Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.
Widmer K; Moake JL; Kent CJ; Yeo YY; Reynolds JP
J Lab Clin Med; 1976 Jan; 87(1):49-57. PubMed ID: 1245783
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructure of clots during isometric contraction.
Cohen I; Gerrard JM; White JG
J Cell Biol; 1982 Jun; 93(3):775-87. PubMed ID: 6889599
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
Carroll RC; Radcliffe RD; Taylor FB; Gerrard JM
J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
[TBL] [Abstract][Full Text] [Related]
11. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
Loza JP; Gurewich V; Johnstone M; Pannell R
Thromb Haemost; 1994 Mar; 71(3):347-52. PubMed ID: 8029800
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots.
De Clerck F; Borgers M; de Gaetano G; Vermylen J
Br J Haematol; 1975 Feb; 29(2):341-8. PubMed ID: 1191554
[TBL] [Abstract][Full Text] [Related]
13. A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots.
Collet JP; Montalescot G; Lesty C; Weisel JW
Circ Res; 2002 Mar; 90(4):428-34. PubMed ID: 11884372
[TBL] [Abstract][Full Text] [Related]
14. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
[TBL] [Abstract][Full Text] [Related]
15. Similarities between platelet contraction and cellular motility during mitosis: role of platelet microtubules in clot retraction.
Chao FC; Shepro D; Tullis JL; Belamarich FA; Curby WA
J Cell Sci; 1976 May; 20(3):569-88. PubMed ID: 1270531
[TBL] [Abstract][Full Text] [Related]
16. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
Sabovic M; Lijnen HR; Keber D; Collen D
Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
[TBL] [Abstract][Full Text] [Related]
17. Blood clot contraction differentially modulates internal and external fibrinolysis.
Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
[TBL] [Abstract][Full Text] [Related]
18. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and biophysical conditions for blood clot lysis.
Sabovic M; Blinc A
Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
[TBL] [Abstract][Full Text] [Related]
20. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
